The Catalyst - A PhRMA Blog | Tom Wilbur

Tom Wilbur is Senior Director of Public Affairs at PhRMA focused on opinion research, message development and political communications. Prior to joining PhRMA in 2019, Tom worked on Capitol Hill and on political campaigns for eight years, most recently responsible for communications and strategy for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom is a proud Michigander and outside of the office enjoys spending time with friends and family, reading, running, hiking, and golfing.

Recent Posts

In their own words: Insured Americans support policy reforms that address access and affordability concerns

By Tom Wilbur | December 14, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience... Read More

In their own words: Financial barriers exacerbate access challenges for insured Americans

By Tom Wilbur | December 8, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that 30% of insured Americans say they face a financial barrier to care, such as unaffordable out-of-pocket costs or a lack of savings... Read More

In their own words: Insured Americans struggle to navigate complex coverage

By Tom Wilbur | October 26, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers. Read More

Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients

By Tom Wilbur | July 12, 2022

As policymakers race to pass government price setting policies, it’s important to examine true public sentiment around such proposals. Voters have made clear that they do not support policies such as... Read More

5 public opinion polling trends to watch

By Tom Wilbur | April 22, 2022

Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize. Read More

Legislation threatens patent protections and future innovation

By Tom Wilbur | January 12, 2022

Recently introduced legislation, the “Restoring the America Invents Act (RAIA),” if enacted, would push the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office to grant more... Read More

Three things to know about so-called Medicare negotiation polling

By Tom Wilbur | November 18, 2021

As policymakers continue to push partisan drug pricing proposals, several polls misrepresenting voter opinion have been circulated to try and justify these flawed policies. These polls fail to... Read More

Recent polling misrepresents public support for Medicare “negotiation”

By Tom Wilbur | August 31, 2021

Proponents of government price setting often misrepresent voters’ opinions on support for allowing the federal government to “negotiate” drug prices. This includes recent polling from advocacy firms... Read More

Myth vs. fact: Polling and Medicare “negotiation”

By Tom Wilbur | August 12, 2021

As some in Washington consider legislation related to prescription medicines and how to best help Americans manage health care costs, government “negotiation” of prescription medicines within... Read More

Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

By Tom Wilbur | July 2, 2021

As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been... Read More

Next